Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Rappa, Alessandra"" wg kryterium: Autor


Wyświetlanie 1-2 z 2
Tytuł :
Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens.
Autorzy :
Malapelle U; Department of Public Health, University of Naples Federico II, Naples, Italy.
Mayo-de-Las-Casas C; Laboratory of Oncology, Pangaea Biotech, Barcelona, Spain.
Molina-Vila MA; Laboratory of Oncology, Pangaea Biotech, Barcelona, Spain.
Rosell R; Catalan Institute of Oncology, Badalona, Spain.; Instituto Oncológico Dr Rosell (IOR), Quirón-Dexeus University Institute, Barcelona, Spain.
Savic S; Institute of Pathology, University Hospital Basel, Basel, Switzerland.
Bihl M; Institute of Pathology, University Hospital Basel, Basel, Switzerland.
Bubendorf L; Institute of Pathology, University Hospital Basel, Basel, Switzerland.
Salto-Tellez M; Molecular Pathology Programme, Centre for Cancer Research and Cell Biology Queen's University Belfast, Belfast, United Kingdom.
de Biase D; Department of Pharmacy and Biotechnology - University of Bologna, Bologna, Italy.
Tallini G; Department of Medicine University of Bologna, Bologna, Italy.
Hwang DH; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
Sholl LM; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
Luthra R; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Weynand B; Department of Pathology, Universitair Ziekenhuis Leuven, Leuven, Belgium.
Vander Borght S; Department of Pathology, Universitair Ziekenhuis Leuven, Leuven, Belgium.
Missiaglia E; Institute of Pathology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Bongiovanni M; Institute of Pathology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Stieber D; National Health Laboratory, Dudelange, Luxembourg.
Vielh P; National Health Laboratory, Dudelange, Luxembourg.
Schmitt F; National Health Laboratory, Dudelange, Luxembourg.
Rappa A; Division of Pathology, European Institute of Oncology, Milan, Italy.
Barberis M; Division of Pathology, European Institute of Oncology, Milan, Italy.
Pepe F; Department of Public Health, University of Naples Federico II, Naples, Italy.
Pisapia P; Department of Public Health, University of Naples Federico II, Naples, Italy.
Serra N; Department of Public Health, University of Naples Federico II, Naples, Italy.
Vigliar E; Department of Public Health, University of Naples Federico II, Naples, Italy.
Bellevicine C; Department of Public Health, University of Naples Federico II, Naples, Italy.
Fassan M; Department of Medicine (DIMED), Surgical Pathology Unit University of Padua, Padua, Italy.
Rugge M; Department of Medicine (DIMED), Surgical Pathology Unit University of Padua, Padua, Italy.
de Andrea CE; Department of Pathology, University Clinic of Navarra, Pamplona, Spain.
Lozano MD; Department of Pathology, University Clinic of Navarra, Pamplona, Spain.
Basolo F; Department of Surgical, Medical and Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy.
Fontanini G; Department of Surgical, Medical and Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy.
Nikiforov YE; Department of Pathology and Laboratory Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Kamel-Reid S; Department of Laboratory Medicine and Pathobiology, University Health Network, Toronto, Ontario, Canada.
da Cunha Santos G; Department of Laboratory Medicine and Pathobiology, University Health Network, Toronto, Ontario, Canada.
Nikiforova MN; Department of Pathology and Laboratory Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Roy-Chowdhuri S; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Troncone G; Department of Public Health, University of Naples Federico II, Naples, Italy.
Pokaż więcej
Corporate Authors :
Molecular Cytopathology Meeting Group
Źródło :
Cancer cytopathology [Cancer Cytopathol] 2017 Aug; Vol. 125 (8), pp. 615-626. Date of Electronic Publication: 2017 May 05.
Typ publikacji :
Journal Article
MeSH Terms :
Colonic Neoplasms/*genetics
DNA Mutational Analysis/*methods
High-Throughput Nucleotide Sequencing/*methods
Sequence Analysis, DNA/*methods
Cell Line ; Cell Line, Tumor ; Class I Phosphatidylinositol 3-Kinases ; ErbB Receptors/genetics ; GTP Phosphohydrolases/genetics ; Gene Frequency ; Humans ; Membrane Proteins/genetics ; Phosphatidylinositol 3-Kinases/genetics ; Proto-Oncogene Proteins B-raf/genetics ; Proto-Oncogene Proteins p21(ras)/genetics ; Real-Time Polymerase Chain Reaction ; Reproducibility of Results
Czasopismo naukowe
Tytuł :
Consistency and reproducibility of next-generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens.
Autorzy :
Pisapia P; Department of Public Health, University of Naples Federico II, Naples, Italy.
Malapelle U; Department of Public Health, University of Naples Federico II, Naples, Italy.
Roma G; AccuRef Diagnostics, Applied Stem Cell, Inc, Milpitas, California.
Saddar S; AccuRef Diagnostics, Applied Stem Cell, Inc, Milpitas, California.
Zheng Q; AccuRef Diagnostics, Applied Stem Cell, Inc, Milpitas, California.
Pepe F; Department of Public Health, University of Naples Federico II, Naples, Italy.
Bruzzese D; Department of Public Health, University of Naples Federico II, Naples, Italy.
Vigliar E; Department of Public Health, University of Naples Federico II, Naples, Italy.
Bellevicine C; Department of Public Health, University of Naples Federico II, Naples, Italy.
Luthra R; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Nikiforov YE; Department of Pathology and Laboratory Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Mayo-de-Las-Casas C; Laboratory of Oncology, Pangaea Oncology, Barcelona, Spain.
Molina-Vila MA; Laboratory of Oncology, Pangaea Oncology, Barcelona, Spain.
Rosell R; Catalan Institute of Oncology, Badalona, Spain.; Rosell Cancer Institute, Quiròn-Dexeus University Institute, Barcelona, Spain.
Bihl M; Institute of Pathology, University Hospital Basel, Basel, Switzerland.
Savic S; Institute of Pathology, University Hospital Basel, Basel, Switzerland.
Bubendorf L; Institute of Pathology, University Hospital Basel, Basel, Switzerland.
de Biase D; Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
Tallini G; Anatomic Pathology, University of Bologna Medical Center, Bologna, Italy.
Hwang DH; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
Sholl LM; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
Vander Borght S; Department of Pathology, University Hospitals Leuven, Leuven, Belgium.
Weynand B; Department of Pathology, University Hospitals Leuven, Leuven, Belgium.
Stieber D; National Health Laboratory, Dudelange, Luxembourg.
Vielh P; National Health Laboratory, Dudelange, Luxembourg.
Rappa A; Division of Pathology, European Institute of Oncology, Milan, Italy.
Barberis M; Division of Pathology, European Institute of Oncology, Milan, Italy.
Fassan M; Surgical Pathology Unit, Department of Medicine, University of Padua, Padua, Italy.
Rugge M; Surgical Pathology Unit, Department of Medicine, University of Padua, Padua, Italy.
De Andrea CE; Department of Pathology, University Clinic of Navarra, Pamplona, Spain.
Lozano MD; Department of Pathology, University Clinic of Navarra, Pamplona, Spain.
Lupi C; Department of Surgical, Medical, and Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy.
Fontanini G; Department of Surgical, Medical, and Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy.
Schmitt F; Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal.; Department of Pathology, Medical Faculty, Porto University, Porto, Portugal.
Dumur CI; Department of Pathology, Virginia Commonwealth University, Richmond, Virginia.
Bisig B; Institute of Pathology, Lausanne University Hospital, Lausanne, Switzerland.
Bongiovanni M; Institute of Pathology, Lausanne University Hospital, Lausanne, Switzerland.
Merkelbach-Bruse S; Institute of Pathology and Center for Molecular Medicine, University of Cologne, Cologne, Germany.
Büttner R; Institute of Pathology and Center for Molecular Medicine, University of Cologne, Cologne, Germany.
Nikiforova MN; Department of Pathology and Laboratory Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Roy-Chowdhuri S; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Troncone G; Department of Public Health, University of Naples Federico II, Naples, Italy.
Pokaż więcej
Corporate Authors :
Molecular Cytopathology Meeting Group
Źródło :
Cancer cytopathology [Cancer Cytopathol] 2019 May; Vol. 127 (5), pp. 285-296. Date of Electronic Publication: 2019 Apr 25.
Typ publikacji :
Journal Article
MeSH Terms :
Mutation*
Biomarkers, Tumor/*genetics
Cytodiagnosis/*methods
DNA Mutational Analysis/*methods
High-Throughput Nucleotide Sequencing/*methods
Neoplasms/*diagnosis
ErbB Receptors/genetics ; Humans ; Neoplasms/genetics ; Proto-Oncogene Proteins B-raf/genetics ; Proto-Oncogene Proteins p21(ras)/genetics ; Reproducibility of Results
Czasopismo naukowe
    Wyświetlanie 1-2 z 2

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies